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Abstract
Nanotechnology enables more precise harmony in health condition via reducing the
dosage amount, improving the delivery of hydrophobic drugs, more specific targeting to
the cancerous sites, and so on. Nevertheless, issues regarding the toxicity of
nanotechnology have begun to call for attention several decades later after the
innovation of nanotechnology. Tools about risk management of nanotechnology have
been developed, but

recently not much evidence recognizes the toxicity of

nanoparticles (NPs) except for some animal studies, which demonstrated organ
damage after the exposure to NPs. Toxicogenomic approach refers to the method
utilizing gene expression to evaluate the chemical toxicity. Databases as Gene
Expression Omnibus and Database for Annotation, Visualization, and Integrated
Discovery are useful platform to provide information about genomic and genetic
pathway. After comparing groups at 4 hours and 24 hours, our study reveals the toxicity
of silicon dioxide (SiO2) NPs to human aortic endothelial cells (HAECs) is affected by
their morphology, and via regulation of different amounts of genes. Cytotoxicity is also
related to materials as SiO2 and poly-amido-amine. More analyses with SiO2 NPs
cultured with mouse macrophages and lung cancer cells, A549 cells, indicates the size
as the attribute of silica nanotoxicity. Smaller SiO2 particles appear to be more toxic in
medium concentration. Among all these three cells (HAECs, mouse macrophages, and
A549 cells), tumor necrosis factor (TNF) signaling pathway is the most highly upregulated pathway. Therefore, the expression of TNF signaling pathway highlights the

v

sub cellular mechanism of toxicity resulted from silica NPs regardless of the morphology
or the size of the particles, and the cell types.

vi

Chapter 1: Introduction for toxicity of nanoparticle and toxicogenomics
1.1 Nanoparticles
The concept of 'nano' was developed more than half a century ago.
Nanoparticles (NPs) demonstrate new physicochemical properties compared to their
bulk materials. A nanometer is one billionth of a meter and is a useful unit of measure in
many fields, such as diagnostic devices and therapeutic drugs in the medical field
(Bhushan, B, 2017.; Kumar et al, 2013; Jain, K. K. 2017).
Not only does nanotechnology provide an alternative way to enhance drug
delivery, the novel traits of NPs also provide useful ways as treatments (Patra et al.,
2018). By applying NPs in drug delivery, the bioavailability of hydrophobic compounds is
possible to be improved, and more precise delivery to diseased sites is able to be
achieved with active targeting or stimulus related targeting. An innovative scope at the
molecular level is built with nanomedicine in both diagnostic and therapeutic field (Kim,
Rutka, & Chan, 2010). Currently, FDA has approved several drugs with nanotechnology
such as PEGylations or liposomes (Bobo, Robinson, Islam, Thurecht, & Corrie, 2016).
The pegylated products have longer circulation time and the drugs delivered by
liposomes appear to have less toxicity (Alconcel, Baas, & Maynard, 2011; James et al.,
1994). Due to the advantage of surface area to volume ratio, less dosage is required for
the

same

therapeutic

effects

as

nanocrystals

(Jens-Uwe,

2008).

The

superparamagnetic character of iron oxide NPs is applied in diagnostic imaging tool
(Bashir, Bhatti, Marin, & Nelson, 2015). A number of NPs have been explored and
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investigated, so a future with less detrimental effects on healthy tissues while treating
diseases will come.
1.2 Silica nanoparticles
The oxidized form of silicon, silica or silica dioxide (SiO2), is the most abundant
compound on earth. Several strengths of using silica nanoparticles (SNPs) are their low
cost, convenience of scale-up, ability to be modified with surface groups, and their
biocompatibility (Nafisi & Maibach, 2015). Fumed or pyrogenic silica has been used in
cosmetics as solvable powder to prevent pigments from aggregation. It also soothes
greasy skin and provides ultraviolet (UV) protection. SNPs also enhance the penetration
of drugs into the dermis layer of the skin (Nafisi & Maibach, 2015). Moreover, they are
used as additive agents in powder to prevent mass formation in food industry
(Athinarayanan, Periasamy, Alsaif, Al-Warthan, & Alshatwi, 2014).
One method to make SNPs was using lysine as catalyst. Hydrolysis and water
separation were involved in the process (Pirutchada et al., 2019). With adding
surfactant as templates, porous SNPs were created (Patil, Verma, Patil, Naik, &
Narkhede, 2019).
Mesoporous silica nanoparticles (MSNPs) were designed for cancer therapy
because they were capable of loading drugs in the tunable pores and being delivered to
the tumor sites. Adding organic part to the mesoporous silica platform improved their
degradation (Guimaraes, Rodrigues, Moreira, & Correia, 2020). For example, loaded
with 5-fluorouracil and NAD(P)H:quinone oxidoreductase 1 inhibitor, MSNPs coated
with lipid bilayers reduced head and neck squamous cell carcinoma volume in mice
model in addition to increasing cancer cell death (Chen et al., 2019). MSNPs loaded

2

with aceclofenac were demonstrated in vitro with the increasing half-life of aceclofenac
(Patil et al., 2019). The delivery route of the drug might also be changed by MSNPs,
such as oral insulin (Juère, Caillard, Marko, Del Favero, & Kleitz, 2020). Beside the
advantage of carrying drugs with the pores, SNPs were easy to be manipulated with the
surface morphology. By modifying the MSNPs with aptamer, Sgc8, doxorubicin was
more selectively delivered to leukemia cells (Yang et al., 2019). With modification of the
surface molecular group, MSNPs could release the loading drugs in acidic environment,
or when they were stimulated by UV light at 365 nm wave length (Wang, Wang, Wang,
Jiang, & Fu, 2019). Another research showed 12 nm SNPs resulted in the death of
astrocytoma U87 cells, one kind of human brain tumor cells, when the concentration is
above 25

g/ml (Lai et al, 2010). Besides, in micro-electromechanical systems, SiO2

film is a common part of cantilever fabrication (Bhatt & Chandra, 2007). When SNPs
were doped with quantum dots and were further conjugated with antibodies, they could
be used as fluorescent dye to visualize leukemia cells (Bottini et al., 2007). A better
image quality derived when SNPs were doped with dyes and contained a gold core
(Galanzha et al., 2017). Together, these evidences revealed the potential popularity of
SNPs in the drug delivery and the diagnosis, although a gap between efficacy and
safety may need to be overcome.
1.3 Toxicity of nanoparticles
In addition to the low delivery rate of NPs to tumors (Wilhelm et al, 2016),
another hurdle is some evidence with toxicity in animal studies and in vitro studies, thus
the term, nanotoxicity (Donaldson et al, 2004; Arora et al, 2011). The nanotoxicity
describes the debilitating effects of nanoparticles on living systems as well as ecological
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systems (Aggarwal et al, 2009). Human bodies are exposed to NPs through ocular,
inhalational, dermal contact, oral and other numerous routes (Oberdörster et al, 2005).
Knowledge of adverse effects about NPs to vascular endothelial cells is crucial,
while intravenous drug delivery is an effective way to treat systemic diseases or
invasively diagnostic devices are adopted to detect blood components. Iron oxide NPs
as imaging NPs induced inflammation response and oxidative stress to human aortic
endothelial cells and umbilical endothelial cells as well as pulmonary fibrosis in animal
model, despite no obvious toxicity in clinic for iron oxide NPs (Li et al. 2014, Zhu et al.
2010, 2011). In addition, CdTe is found to have dose-dependent cytotoxicity in human
umbilical vein endothelial cells (Yan et al, 2011). Hemolytic toxicity of human red blood
cells is found with larger size of modified or unmodified graphene oxide above 300 nm
(Kiew et al, 2016; Liao et al, 2011). TiO2 nanobelts (TiO2-NB) are considered more toxic
to THP-1 cells than multi-walled carbon nanotubes since evidence shows TiO2-NB
regulates gene pathways with inflammation, apoptosis and cell cycle arrest (Tilton et al,
2013). The shape of SiO2 NPs as well as functional groups of poly(amido amine)
(PAMAM) dendrimers have different levels of toxicity on human aortic endothelial cells.
Spherical shape SiO2 NPs are toxic at lower concentration than worm shape SiO2.
Carboxyl ended dendrimers seem to have less toxic effect than amine ended
dendrimers (Moos et al, 2013).
1.4 Toxicogenomics
As early as in 1980s, scientists began to investigate the relationship between
genes and toxicity. The niridazol, an agent against schistosomiasis, was researched for
the relationship between its neurotoxicity and the Ah locus of mice (Blumer, Simpson,
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Lucas, & Webster, 1980). Stemmed from the human genome project, plates coated with
genetic materials as DNA arrays were being used to test the chemical toxicity, an
approach named as a toxicogenomic model. Advocated by Lovett (2000), if this
approach could overcome the puzzles between untested chemicals and actual
outcomes such as real illness, toxicogenomic models might save the cost of
experimental animals and detect chronic diseases as early as possible (Lovett, 2000).
Paved with this concept, big genomic data used to predict liver injury such as
fibrotic and necrotic pathology with drug dosage in humans and mice was developed in
the following years (Kohonen et al., 2017). In addition, it is possible to track the
molecular pathways related with hepatitis B virus (HBV) in hepatocellular carcinoma
(HCC). With the amount of 113 overlapping genes derived from two datasets, AMPK
signaling pathway and responses to cadmium ions were likely to be involved in HBV
related HCC (Li et al., 2020).
Toxicogenomic models can also be applied to assess nanotoxicities. Several
databases were built despite scarce research in nanotoxicities. The NanoSolveIT
project is an example, aimed to integrate these databases to provide a platform to
predict adverse effects of nanomaterials based on their infrastructure, gene expression
data, and various endpoints (Afantitis et al., 2020).
Through studying genomic expression of human cell lines after exposure to NPs,
more understanding in the mechanism of toxicity caused by NPs is able to be revealed
(Moos et al., 2013). In this project, we analyzed public transcriptome data on the toxicity
of two drug delivery nanoplatforms for primary human aortic endothelial cells, as well as
the toxicity of silica NPs on mice macrophages and lung cancer cells. The identified
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genes and gene pathways may assist the risk management of these nanoplatforms.
More specification of the affected genes owns the potential to assist the pharmaceutical
industry in designing dosage and morphology of coming nano-components.
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Chapter 2: Silica nanoparticle effects on human heart epithelial cell
2.1 Introduction
In this chapter, the transcriptional responses of primary HAECs to SNPs and
PAMAM dendrimers were identified. We tried to see the gene changes of endothelial
cells caused by these drug delivery nanoplatforms.
2.2 Methods and data set
The study was based on a National Center for Biotechnology Information’s
(NCBI) Gene Expression Omnibus (GEO) data set, GSE35142. In this data set, the
effects on gene expression of HAECs by two different shapes of SNPs (sphere and
worm) and carboxyl (COOH) PAMAM group and the amine (NH2) PAMAM were
investigated. The chemical structure of PAMAM was shown in Figure 1.
2.2.1 Gene Expression Omnibus database
Gene expression data was analyzed with the NCBI’s GEO database (Edgar &
Barrett, 2006). After searching with the keyword as “human aortic endothelial cells,
silicon dioxide,” further information was retrieved with clicking the “Analyze with
GEO2R”

tab

(Figure

2).

The

website

address

was

as

follows:

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35142.
2.2.2 Define groups
The SiO2 and PAMAM groups were defined in NCBI GEO2R analyzer. Groups of
the same material either SiO2 or the dendrimer were compared between different time
period as 4 hr and 24 hr. Groups with various materials modified differently were also
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compared within the same time period, 4 hr and 24 hr respectively. For example, the
group name was entered as “SiO2 worm 4hr” after clicking the tab “define groups” and
then select the following items with “200nm SiO2 worm 4hr incubation 100 g/ml.” Next,
another group named as “SiO2 sphere 4hr” was created and filled with “200nm SiO 2
spheres 4hr incubation 73.38 g/ml.”

(a) core of PAMAM

(b) G2-NH2 PAMAM

Figure 1. Chemical structure of PAMAM
Note. (a) The core of PAMAM was similar to ethane in the central with hydrogen atoms replaced
by tertiary amine nitrogen atoms. The surface layers were four primary amide groups. In other
words, ethylene diamine was used as a core initiator. (b) Dendrimers were synthesized with
divergent or convergent process. The nitrogen in the amide groups acted as nitrogen in
ethylene diamine and this forms one generation. Once the amide group was replaced by
carboxyl group, this forms a half generation.

2.2.3 Refine the results of expressed gene
During this process, the actions were to hit the “TOP250” tab and click the “Save
all results” link to open a new window. The data of gene lists was saved as text files
(*.txt) after the processing is done. For statistical significance, the collected gene lists
were organized by eliminating data with adjusted p value over 0.05. The up and down
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regulated genes were further adjusted in accordance with log (Fold Change), which was
labeled as log FC, more or less than 1 with Microsoft Excel software. The value of fold
change (FC) as 1.25 was also considered.

Figure 2. Icon of the GEO database
Note. The icon was from the websites of Gene Expression Omnibus. In the figure, the tab for
analyzing at the bottom of the website page was shown below.

2.2.4 Generation of genetic pathways
The refined gene list was entered into the Database for Annotation, Visualization
and Integrated Discovery (DAVID) (https://david.ncifcrf.gov) to generate Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathways (Dennis et al., 2003). The
gene list was analyzed through functional annotation domain and under official gene
symbol. Homo sapiens was designated as our species. The species was changed in
mouse model.
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2.2.5 Computer hardware system and settings
The databases were run by Dell OptiPlex 3060 desktop computer core and Mac.
The operating systems include Windows 10 developed by Microsoft Corporation and the
search engine is Google Chrome.
2.3 Results
2.3.1 Differentially expressed genes
Four materials, including worm shaped (100 g/ml) and spherical shaped (73.38
g/ml) SiO2 NPs, sizing around 200nm, COOH-PAMAM and NH2-PAMAM dendrimer
were analyzed. The gene expression level difference of each material between 4 hr and
24 hr were compared. The survivals of HAECs cells cultured with these 4 materials
were also obtained.
In toxicogenomics, the number of differentially expressed genes was a good
measurement to evaluate the effects of treatment on a biological system. In our studies,
we found there was a strong association between the number of differentially expressed
genes and cell viability. In the HAECs data set, cell survival and transcriptome profiles
of the endothelial cells were observed after 4 hours and 24 hours with conditions when
cells were transfected with NPs of various morphologies and compositions. For
instance, the quantities of regulated genes by spherical SNPs were analyzed between 4
and 24 hours.
As shown in Table 1, after 24 hours, there was a 57% (from 100% to 43%)
decline in cell population for cells treated with SiO2 sphere shape NPs at a
concentration of 100

g/ml. Between 4 hours and 24 hours post-transfection, 4411

genes were found to be regulated at adjusted p-value < 0.05 and at least 1.25 fold
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change. Transfection with worm formed SiO2 NPs resulted in a 19% (decreasing from
100% to 81%) cell mortality rate and 368 differentially regulated genes after 24 hrs.
Transfection with either the COOH-PAMAM nano construct or the NH2-PAMAM nano
construct resulted in no cell mortality. A total of 2 and 15 differentially expressed genes
were found for NH2-PAMAM and COOH-PAMAM material by comparing transcriptome
of 4 hours with 24 hours.

Table 1. Association of gene number and cell survival

#Regulated genes
Nano_Construct

Concentration

Cell Survivor%

(4hr vs 24hr)

SiO2_Worm

100 g/ml

81

368

SiO2_Sphere

73 g/ml

43

4426

G3.5-COOH_PAMAM

0.5 M

103

15

G4-NH2_PAMAM

0.5 M

100

2

Note. The regulated gene number is composed of both up and down regulated genes. The gene
number are values after comparing 24 hr group with 4 hr group of different nano constructs, and
the results with blank gene identity are eliminated.

The linear relationship between the number of differentially expressed genes and
the percentage of cell survival was shown in the Figure 3; there was a positive
correlation between the cytotoxicity of the NPs and the number of differentially
11

expressed genes, of which a greater cell mortality rate was associated with a higher
number of dysregulated genes. Since no cytotoxicity was observed with PAMAM
groups, we defined a control group with all PAMAM materials. The control group was
compared with worm and sphere shaped SNPs selected in one group.

5000
SiO2_Sphere

Number of differntially expressed genes

4000

3000

2000

1000
SiO2_Worm
NH2_PAMAM
0

-20
-1000

COOH_PAMAM

0

20

40

60

80

100

120

Percentage of cell survival

Figure 3. The association between the number of differentially expressed genes with
cell survival
Note. The correlation was noted in the figure. Generally, the more the differential expressed
genes were affected, the less survival chance the cells had. Spherical SNPs affected more
genes than worm shaped SNPs, so the percentage of HAECs cultured with the spherical SNPs
was less. Moreover, the figure showed SNPs were more toxic than PAMAM.

The levels of the differentially regulated genes as a result of comparing SNPs
with PAMAM were demonstrated in Figure 4. More genes were up regulated by the
12

group of SNPs than the number of genes down regulated when SNPs was compared
with PAMAM.

Figure 4. Gene regulated by silica nanoparticles
Note. The genes are compared by using PAMAM as the control group. The red spots indicated
the up regulated genes, so do the green spots. There are 2031 up-regulated and 1662 downregulated genes for silica material comparing with PAMAM.

2.3.2 Gene pathways and ontology analysis
The genetic pathways in Figure 5 were listed according to the level of fold
change. Among these pathways, TNF signaling pathways were the most overly
expressed one when comparing SNPs with PAMAM as described in the previous
section. More details with the genes involved in the genetic pathways were given in
Table 2.
13

−log10(FDR)

10

8

6

4

2

0
hsa04668:TNF signaling pathway
hsa04010:MAPK signaling pathway
hsa05166:HTLV−I infection
hsa05323:Rheumatoid arthritis
hsa05134:Legionellosis
hsa05202:Transcriptional misregulation in cancer

hsa05200:Pathways in cancer
hsa05161:Hepatitis B

silica_worm

hsa04380:Osteoclast differentiation

hsa04064:NF−kappa B signaling pathway
hsa05140:Leishmaniasis
hsa04722:Neurotrophin signaling pathway
hsa04621:NOD−like receptor signaling pathway
hsa05144:Malaria
hsa05168:Herpes simplex infection

Figure 5. Enriched gene pathways in up-regulated genes
Note. TNF signaling pathway has the most statistical significance. These pathways are derived
from the gene list by comparing silica NPs with PAMAM.
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Table 2. Enriched Pathways in up-regulated genes in human sample

Term

hsa04668:TNF
signaling pathway

hsa04010:MAPK
signaling pathway

hsa05166:HTLV-I
infection

Count

29

40

39

PValue

Genes

Fold
Enrichment

5.13E-11

TRAF1, CSF2, TNF, CCL2,
PTGS2, CXCL3, CXCL2,
NFKBIA, NFKB1, ATF2,
VCAM1, LIF, FOS, CCL20,
MAP3K8, BCL3, IL1B,
ICAM1, SOCS3, MAP2K3,
CREB1, MAPK11, CREB5,
BIRC3, JUNB, RPS6KA5,
JUN, TNFAIP3, SELE

4.27

6.68E-08

1.46E-07

FGF5, TNF, DUSP10,
NFKB1, HSPA1A,
CACNB3, NFKB2, FGF12,
ATF2, FOS, BDNF, RAC3,
ELK4, MAP3K1, MAPT,
SOS1, MAP3K8, DUSP16,
RASGRP2, IL1B, IL1A,
NFATC1, MAP2K5,
LAMTOR3, MAP2K3,
RELB, NR4A1, MAPK11,
DDIT3, CDC25B, MAP4K3,
RPS6KA5, DUSP5,
RPS6KA6, DUSP2,
DUSP1, RPS6KA2, JUN,
GADD45B, MAP3K11

2.49

1.90E-04

4.66E-07

CSF2, CRTC2, NRP1, TNF,
CREM, ADCY6, NFKBIA,
NFKB1, NFYB, ITGB2,
NFKB2, CANX, ATF1,
ATF2, VCAM1, FOS, ELK4,
MAP3K1, NFATC2, TBPL1,
NFATC1, FZD9, EGR1,
ZFP36, ICAM1, KAT2B,
EGR2, SLC25A6, CREB1,
RELB, POLB, RB1, FZD5,
DVL1, CDKN1A, ATF3,
ETS1, JUN, WNT9A

2.42

6.06E-04

FDR (%)

Note. Details of the genes involved in different pathways up regulated by SNPs. The gene
abbreviations, the count of genes in each pathway, p-values, adjusted p-values (FDR), and the
value of logarithmic function with pathway fold change (fold enrichment) were listed in the table.
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Table 2. (Continued)

hsa05323:Rheumatoid
arthritis

hsa05134:Legionellosis

hsa05202:Transcriptional
misregulation in cancer

hsa04380:Osteoclast
differentiation

hsa05200:Pathways in
cancer

17

13

25

21

44

1.07E-04

ICAM1, CSF2, TNF, CCL2,
TLR2, CXCL8, ACP5,
ITGB2, ATP6V1B2, FOS,
CCL20, JUN, ATP6V1E1,
TEK, IL1B, IL1A, CD28

3.04

0.14

1.08E-04

EEF1A1, TNF, CXCL3,
CXCL2, TLR2, CXCL8,
NFKBIA, EEF1G, IL1B,
NFKB1, ITGB2, HSPA1A,
NFKB2

3.79

0.14

1.23E-04

CCNT2, TRAF1, BMI1,
CEBPA, NFKBIZ, CSF2,
RXRB, RXRA, MET,
CXCL8, NFKB1, SIX4,
DDIT3, ATF1, MLF1,
CDKN1A, CDKN1B,
TAF15, REL, ELK4, PER2,
MDM2, RARA, JMJD1C,
KLF3

2.36

0.16

1.96E-04

TNF, FOSL2, SOCS3,
CREB1, RELB, NFKBIA,
ACP5, NFKB1, MAPK11,
NFKB2, FOSB, STAT1,
JUNB, CYLD, FOS,
SQSTM1, JUN, IL1B,
NFATC2, IL1A, NFATC1

2.52

0.26

2.54E-04

TRAF1, FGF5, PTGS2,
PGF, ADCY6, CXCL8,
NFKBIA, KITLG, NFKB1,
NFKB2, FGF12, ITGB1,
GLI1, FOS, RAC3, SOS1,
RASGRP2, RALB, NKX3-1,
RARA, TRAF4, FZD9,
CEBPA, RXRB, RXRA,
MET, RB1, FZD5, STAT1,
BIRC3, DAPK3, RALGDS,
DVL1, CDKN1A, CDKN1B,
PLCG1, GNAQ, ETS1,
JUN, RASSF1, MDM2,
LAMC2, GNAS, WNT9A

1.76

0.33
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Table 2. (Continued)

hsa05161:Hepatitis B

22

2.90E-04

hsa04064:NF-kappa B
signaling pathway

16

3.23E-04

hsa05140:Leishmaniasis

hsa04722:Neurotrophin
signaling pathway

14

19

4.39E-04

5.05E-04

hsa04621:NOD-like
receptor signaling
pathway

12

6.46E-04

hsa05144:Malaria

11

8.27E-04

hsa05168:Herpes
simplex infection

23

0.0026

EGR3, TNF, EGR2,
CREB1, DDB1, TLR2,
CXCL8, NFKBIA, NFKB1,
CREB5, RB1, STAT1,
ATF2, STAT6, FOS,
CDKN1A, CDKN1B, JUN,
MAP3K1, TICAM1,
NFATC2, NFATC1
TRAF1, ICAM1, TNF,
PTGS2, RELB, CXCL8,
NFKBIA, UBE2I, NFKB1,
NFKB2, BIRC3, VCAM1,
PLCG1, TICAM1, IL1B,
TNFAIP3
TNF, PTGS2, NFKBIB,
TLR2, NFKBIA, NFKB1,
ITGB2, MAPK11, STAT1,
ITGB1, FOS, JUN, IL1B,
IL1A
IRAK2, NFKBIE, NFKBIB,
NFKBIA, NFKB1,
MAPK11, RPS6KA5,
RPS6KA6, BDNF, PLCG1,
RPS6KA2, JUN, MAP3K1,
SOS1, GAB1, PSEN2,
CAMK2D, RIPK2,
MAP2K5
TNF, CCL2, NFKBIB,
CXCL2, CXCL8, RIPK2,
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Chapter 3: Silica nanoparticle effects on mouse macrophage
3.1 Introduction
In this chapter, the gene expression changes of RAW 264.7 mouse macrophage
cells regulated by two different sizes of amorphous SNPs (10 nm and 500 nm) at three
different doses were identified. These three doses were labeled as low, medium, and
high concentration.
3.2 Data set
The study described in this chapter was based on a NCBI GEO data set,
GSE13005. In this data set, the effects on gene expression of RAW 264.7 mouse
macrophage cells by 10 nm silica at 5 (low), 20 (medium), or 50 (high)

g/ml for 2

hours, as well as 500 nm silica at 250 (low), 500 (medium), or 1000 (high) g/ml, were
investigated.
3.3 Results
3.3.1 Differentially expressed genes
The results of the differentially expressed genes with 10 nm and 500 nm SNPs
were shown in Figure 6 and Figure 7 respectively. The colored spots, as green and red,
represented the results with statistical significance of adjust p value (q value) less than
0.05 and the Fold Change more or less than 1.25. The results without statistically
significance were shown as black spots. At high dosage, more than 300 genes were
regulated by both 10 nm and 500 nm SNPs. On the contrary, 10 nm particles were able
to cause more gene changes than 500 nm NPs at medium dosage (Figure 8).
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Figure 6. Regulated genes by 10nm SNPs at low, medium and high concentration
Note. More differentially expressed genes were noted when the concentration became higher.
Nevertheless, most genes (182) were up regulated with the medium concentration. The q value
here was defined as adjust p value.
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Figure 7. Regulated genes by 500nm SNPs at low, medium and high concentration
Note. Higher concentration was related to more differentially expressed genes.
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2

3.3.2 Gene pathways and ontology analysis
Some enriched KEGG pathways with FDR value less than 0.05 were identified in
up-regulated genes by NPs (Figure 8). Other than the medium concentration, 500 nm
SNPs regulated more gene pathways than 10 nm SNPs at high concentration for 2
hours. TNF signaling pathway (mmu04668) was the top pathway for both materials.
Other common gene pathways regulated by these two sized NPs included MAPK
signaling pathway, HTLV-I infection, cytokine-cytokine receptor interactions and Chagas
disease. There was no enriched gene pathway shown in genes down regulated by 10
nm or 500 nm SNPs.
500

Number of Differentially Expressed Genes

400
300
200
0

100

The number of regulated genes

Silica_10nm
Silica_500nm

Low
Low

Middle
Medium

High
High

Concentration

Figure 8. The number of regulated genes by different sizes SNPs at low, medium and
high concentration
Note. 10 nm SNPs regulated more genes in medium concentration than 500 nm SNPs. More
genes were affected when the concentration became higher.
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Figure 9. Enriched gene pathways in up-regulated genes with both sized SNPs
Note. TNF signaling pathway was up-regulated in both 10 nm and 500 nm groups. Genetic
pathways of low and medium concentration were not shown.
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Chapter 4: Silica nanoparticle effects on A549 lung cancer cells
4.1 Introduction
In this chapter, the gene expression changes of A549 lung cell lines regulated by
two different sizes of SNPs (9 nm and 18 nm of diameter) were identified.
4.2 Data set
The study was based on a NCBI GEO data set, GSE53700. In this data set, the
effects on gene expression of A549 lung cancer cells by two different sizes of SNPs (9
nm and 18 nm of diameter) were investigated.
4.3 Results
4.3.1 Differentially expressed genes
In the group with 9 nm SNPs, 910 genes were up-regulated and 340 genes were
down-regulated. On the other hand, no differentially expressed genes were found in the
group with 18 nm SNPs (Figure 10). The genes that were expressed twice more were
analyzed with fold change as 2 and log (Fold Change) as 1.
4.3.2 Gene pathways and ontology analysis
More than 20 KEGG pathways were found in A549 lung cancer cell lines after 3
hour exposure to 9 nm SNPs as shown in Figure 11. Among them, 18 KEGG pathways
with Benjamini value less than 0.05 reached statistical significance. These pathways
are TNF signaling pathway, pathways in cancer, rheumatoid arthritis, transcriptional
regulation in cancer, cytokine-cytokine-receptor interaction, TGF-beta signaling
pathway, hematopoietic cell lineage, MAPK signaling pathway, signaling pathways
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regulating pluripotency of stem cells, proteoglycans in cancer, NF-kappa B signaling
pathway, HTLV-I infection, amoebiasis, Fc epsilon RI signaling pathway, NOD-like
receptor signaling pathway and so on. TNF signaling pathway again appears in the list
as the most significant regulatory pathway of SNPs.
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Figure 10. Regulated genes by different sizes SNPs in A549 cells
Note. More genes were regulated in 9 nm group than 18 nm group. No genes were found
regulated in the 18 nm group. The q value here was equal to adjust p value.
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Figure 11. Enriched gene pathways in up-regulated genes in A549 cells
Note. TNF signaling pathway was up-regulated the most by 9 nm SNPs with A549 cells as
noted in the figure. No down regulated gene pathways were found.
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Chapter 5: Possible pathways and mechanism of toxicity caused by silica
nanoparticles
TNF signaling pathway is a crucial way in regulating cell survival and death
(Figure 11). Tumor necrosis factor (TNF) is a term coined by researcher as a serum
factor that results in tumor regression. Shrinkage of tumor size and hemorrhagic
necrosis are found after injection of lipopolysaccharide and BCG in a mouse model
(Old, 1985).
Two pathways with TNF-R1 and TNF R2 receptors are found currently, and there
are two molecules, TNF alpha and TNF beta. More studies are done on TNF-R1 and
TNA alpha. Multiprotein signaling complex is formed during the process TNF signaling
pathway. A variety of human diseases are related to this pathway, and it is the target of
drug in immune disease such as rheumatoid arthritis. After extracellular domain of TNFR1 binds to TNF, a homotrimer of 157 amino acid subunits, TNF-R1’s intracellular
domain (ICD) is revealed by separating from silencer of death domains (SODD) (Chen
& Goeddel, 2002). ICD then binds to adaptor protein, TNF receptor-associated death
domain (TRADD), and recruits additional adaptor proteins: TNF-R-associated factor 2
(TRAF2), receptor-interacting protein (RIP), and Fas-associated death domain (FADD).
The recruiting of Caspase-8 following FADD initiates a protease cascade for apoptosis.
Other parts of the TNF and TNF-R1 signaling pathway involve various activations of
enzymes result in anti-apoptosis or NFκB activation (Chen & Goeddel, 2002). In
endothelial cells, TNF induces cell death and a procoagulation state. However, studies
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show TNF-R2 in favor of cell apoptosis rather than TNF-R1 pathway, which reduces cell
death (Nawroth & Stern, 1987; Okada et al, 2001).
TNF alpha is a soluble polypeptide factor, or a cytokine, that serves as crosstalk
between cells. It is composed of 20 proteins from the 18 genes located on the position
of chromosome 7p21. It is produced by many cells including active B and T cells, mast
cells, macrophages and monocytes, etcetera (Weinberg & Buchholz, 2006). The major
source of TNF alpha is from activated macrophages. In addition to effects on antiviral
activities, cellular metabolism, growth regulation of cells, coagulation processes, and
insulin response, TNF alpha can trigger series of inflammatory processes, favoring
antimicrobial response with inflammatory CD4 T cells (Th1) than atopic or allergic
response with helper CD4 T cells (Th2). In endothelial cells, it aggravates vascular
leakage and recruits lymphocytes. It also activates macrophages, increasing nitric oxide
production (Weinberg & Buchholz, 2006). Therefore, some drugs focus on TNF alpha
as the target to treat the disease. Other than TNF-alpha, which is mainly related to
chronic systemic inflammatory response, TNF-beta is secreted by T cells and enhances
phagocytic function of neutrophil and macrophages as well as cytotoxicity on tumor cells
(Weinberg & Buchholz, 2006).
Several studies use TNF alpha to evaluate the effect like oxidative stress by
SNPs on cells. Silica nanoparticles around 10 nm were found to induce TNF alpha in 3D
alveolar model as well as interleukin-1 in a concentration dependent manner (Skuland
et al., 2020). Moreover, spherical SNPs between 10 and 50 nm induced TNF alpha
mRNA

expression

in

human

lung

fibroblast

cells

by

quantitative

RT-PCR

(Athinarayanan, Periasamy, Alsaif, Al-Warthan, & Alshatwi, 2014). Another study with
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human lung fibroblast cells showed silica in nano form had more TNF alpha expression
than their micro form with western blotting, indicating more toxicity in nano form
(Ahmad, Khan, Patil, & Chauhan, 2012). This result was similar to the result with 3D
alveolar model. TNF alpha was not specific to SNPs. Different nanomaterials could
induce TNF alpha rather than SNPs in human monocytes (Ainslie et al., 2009), and
SNPs induced other pathways, too. One major component of silymarin, silibinin, was
found to reduce the TNF alpha expression due to SNPs as wells as mitogen-activated
protein kinase and thioredoxin-interacting protein (Lim et al., 2020). These evidences
are consistent with our study that silica nanoparticles regulate cell toxicity through TNF
signaling pathway. Moreover, common genes are found in human and mouse model of
TNF signaling pathway as shown in Table 3.

Table 3. TNF Pathways with up-regulated genes in human and mouse cells

Term

hsa04668:TNF
signaling pathway

mmu04668:TNF
signaling pathway

Count

29

11

PValue

Genes

Fold
Enrichment

FDR (%)

5.13E-11

TRAF1, CSF2, TNF, CCL2,
PTGS2, CXCL3, CXCL2,
NFKBIA, NFKB1, ATF2,
VCAM1, LIF, FOS, CCL20,
MAP3K8, BCL3, IL1B,
ICAM1, SOCS3, MAP2K3,
CREB1, MAPK11, CREB5,
BIRC3, JUNB, RPS6KA5,
JUN, TNFAIP3, SELE

4.27

6.68E-08

7.58E-09

LIF, CFLAR, FOS, CCL2,
TNF, PTGS2, JUN, CSF1,
CXCL2, EDN1, JUNB

12.94

8.86E-08

Note. Different genes are regulated in human versus mouse model.
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Figure 12. TNF signaling pathway
Note. TNF signaling pathway as membranous receptor (TNFR1 or TNFR2) interacts with TNF signal. A series of reactions inside the
cell are demonstrated, leading to cell death. This is a concise figure. More proteins and chemical compounds can be involved in this
pathway.
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Chapter 6: Conclusion
In summary, gene number is related to cell survival in human aortic endothelial
cells cultured with different materials, shapes, and functional group. Small sized silica
nanoparticles are more toxic in medium concentration in mouse macrophages and lung
cancer cells. Tumor necrosis factor signaling pathway is the main pathway involved in
the toxicity mechanism of silica nanoparticles no matter what the size, the shape of the
silica NPs is, or no matter what kind of the cells is.
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Appendix

Abbreviation list
COOH: carboxyl
DAVID: Database for Annotation, Visualization and Integrated Discovery
GEO: Gene Expression Omnibus
HAECs: human aortic endothelial cells
HBV: hepatitis B virus
HCC: hepatocellular carcinoma
MSNPs: mesoporous silica nanoparticles
NCBI: National Center for Biotechnology Information
NH2: amine
NPs: nanoparticles
PAMAM: poly-amido-amine
SiO2: silicon dioxide
SNPs: silica nanoparticles
TiO2: titanium dioxide
TiO2-NB: nanobelts
TNF: tumor necrosis factor
UV: ultraviolet
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